Dr. Karan Datta Kale – Surgical Oncologist in Mumbai

Dr. Karan Datta Kale is a Consultant Surgical Oncologist at Fortis Hospital, Mulund, Mumbai. His primary expertise lies in hepatopancreatobiliary and gastrointestinal cancer surgery, including complex operations for tumours of the liver, pancreas, bile ducts, gallbladder and digestive tract. Fortis Healthcare reports seven years of experience.

Dr. Kale holds MBBS, MS in General Surgery and MCh in Surgical Oncology. He has undertaken advanced fellowship training at Tata Memorial Hospital, Mumbai, in pancreaticobiliary, upper gastrointestinal and retroperitoneal sarcoma oncology. His specialist training focuses on the surgical treatment of complex abdominal cancers.

His clinical practice includes liver cancer surgery, pancreatic tumour surgery and treatment of biliary tract malignancies. Operations such as liver resection and pancreaticoduodenectomy require detailed assessment of tumour extent, blood vessel involvement and overall surgical fitness. Treatment planning may include chemotherapy or other therapies before or after surgery.

Dr. Karan Datta Kale also manages gastrointestinal cancers, including stomach, oesophageal and colorectal malignancies. Surgical treatment depends on cancer location, stage and the patient's medical condition. Procedures may involve removing affected tissue and regional lymph nodes as part of a multidisciplinary oncology treatment plan.

Retroperitoneal sarcoma is another documented area of his expertise. These tumours develop deep within the abdomen and can involve nearby organs and major blood vessels. Surgery requires detailed imaging and careful planning to assess whether complete tumour removal can be achieved safely.

Dr. Kale has participated in oncology conferences, scientific presentations and surgical oncology publications. Patients seeking specialist surgical evaluation for liver, pancreatic, gastrointestinal or retroperitoneal cancers in Mumbai may consult him for diagnostic review, surgical planning and coordinated multidisciplinary care.

Liver Cancer Surgery (Hepatectomy)

Hepatectomy involves removing a portion of the liver affected by selected malignant tumours. Surgery may be considered when the cancer is technically removable and sufficient healthy liver function can be preserved. Planning requires detailed imaging, assessment of liver reserve and multidisciplinary review.

Pancreatic Cancer Surgery

Pancreatic cancer surgery may be considered for selected patients whose tumours can be removed safely. The specific operation depends on tumour location and involvement of surrounding structures. Preoperative assessment considers cancer stage, vascular anatomy, nutritional status and the need for additional cancer treatments.

Whipple Procedure

The Whipple procedure, or pancreaticoduodenectomy, is a complex operation commonly used for selected tumours involving the pancreatic head or surrounding region. It may involve removing parts of the pancreas, duodenum and bile duct followed by reconstruction. Careful patient selection and specialist postoperative monitoring are essential.

Bile Duct Cancer Surgery

Cholangiocarcinoma is a cancer affecting the bile ducts. Surgery may involve removal of affected ducts and, depending on tumour location, parts of the liver or pancreas. Treatment planning requires detailed imaging and assessment of whether complete tumour removal is feasible.

Gallbladder Cancer Surgery

Gallbladder cancer surgery depends on the tumour stage and extent of disease. Selected patients may require removal of the gallbladder together with adjacent liver tissue or lymph nodes. Multidisciplinary assessment helps determine whether surgery offers an appropriate treatment option.

Stomach Cancer Surgery (Gastrectomy)

Gastrectomy removes part or all of the stomach for selected gastric cancers. Surgery may also involve removal of nearby lymph nodes. The choice of procedure depends on tumour location, stage and overall health, with nutritional care forming an important component of recovery.

Oesophageal Cancer Surgery

Oesophageal cancer surgery may involve removing the affected portion of the food pipe and reconstructing the digestive passage. Treatment is considered according to cancer stage, tumour location and the patient's fitness. Chemotherapy or radiation may form part of the overall treatment plan.

Colorectal Cancer Surgery

Colorectal cancer surgery removes affected segments of the colon or rectum along with appropriate surrounding tissue. The operative approach depends on cancer location and stage. Some patients may require additional treatments or a temporary or permanent stoma depending on clinical circumstances.

Retroperitoneal Sarcoma Excision

Retroperitoneal sarcomas are uncommon cancers arising in the tissues behind the abdominal cavity. Surgical treatment may require removal of a large tumour and occasionally nearby affected organs. Detailed imaging and multidisciplinary planning are important because these tumours can lie close to major blood vessels.

Liver Metastasis Resection

Liver metastasis resection removes selected cancer deposits that have spread to the liver from another organ. Suitability depends on the primary cancer, distribution of liver lesions and whether sufficient liver tissue can remain. Surgery is often considered alongside systemic cancer treatment.

Neuroendocrine Tumour Surgery

Neuroendocrine tumours develop from specialised cells that can produce hormones. Surgery may be considered for certain localised or selected metastatic tumours. The treatment approach depends on tumour site, grade, growth pattern and whether symptoms arise from hormone production.

Staging Laparoscopy

Staging laparoscopy is a minimally invasive procedure used to inspect the abdominal cavity and identify cancer spread that may not be visible on imaging. It may help determine whether a planned major cancer operation is appropriate. Tissue samples can be collected when clinically indicated.

Cytoreductive Cancer Surgery

Cytoreductive surgery aims to remove visible tumour deposits in selected abdominal cancers. It may be considered as part of a specialised multidisciplinary treatment plan. Suitability depends on cancer type, distribution, patient health and the expected balance of benefits and surgical risks.